Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q116782638 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000241.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q116782638 | ||
| 035 | ‡a (OCoLC)Q116782638 | ||
| 100 | 0 | ‡a Jae Bock Chung ‡c researcher ‡9 en | |
| 670 | ‡a Author's Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. | ||
| 670 | ‡a Author's Best options for preoperative biliary drainage in patients with Klatskin tumors | ||
| 670 | ‡a Author's Bile acid analysis in biliary tract cancer. | ||
| 670 | ‡a Author's BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. | ||
| 670 | ‡a Author's Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2. | ||
| 670 | ‡a Author's Clinical characteristics of long-term survivors of inoperable pancreatic cancer: an 8-year cohort analysis in Korea. | ||
| 670 | ‡a Author's Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. | ||
| 670 | ‡a Author's Clinicopathologic characteristics associated with complications and long-term outcomes of endoscopic papillectomy for adenoma | ||
| 670 | ‡a Author's Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period | ||
| 670 | ‡a Author's Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction. | ||
| 670 | ‡a Author's Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer | ||
| 670 | ‡a Author's Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort study | ||
| 670 | ‡a Author's Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer. | ||
| 670 | ‡a Author's Endoscopic treatment of a pediatric patient with acute pancreatitis caused by anomalous union of pancreaticobiliary duct combined with incomplete pancreatic divisum | ||
| 670 | ‡a Author's Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer. | ||
| 670 | ‡a Author's Hepatic artery pseudoaneurysm associated with plastic biliary stent | ||
| 670 | ‡a Author's Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma. | ||
| 670 | ‡a Author's High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. | ||
| 670 | ‡a Author's Hypoechoic foci on EUS are simple and strong predictive factors for neoplastic gallbladder polyps. | ||
| 670 | ‡a Author's Long-term follow up of gallbladder polyps. | ||
| 670 | ‡a Author's Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells. | ||
| 670 | ‡a Author's Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer. | ||
| 670 | ‡a Author's Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. | ||
| 670 | ‡a Author's Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response | ||
| 670 | ‡a Author's Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer. | ||
| 670 | ‡a Author's Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. | ||
| 670 | ‡a Author's Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses | ||
| 670 | ‡a Author's Radiotherapy prolongs biliary metal stent patency in malignant pancreatobiliary obstructions. | ||
| 670 | ‡a Author's Signet ring cell carcinoma of the extrahepatic bile duct. | ||
| 670 | ‡a Author's The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. | ||
| 670 | ‡a Author's The efficacy of endoscopic palliation of obstructive jaundice in hepatocellular carcinoma | ||
| 670 | ‡a Author's The relationship of anatomic variation of pancreatic ductal system and pancreaticobiliary diseases. | ||
| 670 | ‡a Author's The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer | ||
| 670 | ‡a Author's Tuberculous mesenteric lymphadenitis involving the gastric wall: case report | ||
| 670 | ‡a Author's Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis | ||
| 670 | ‡a Author's Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. | ||
| 670 | ‡a Author's Visceral Obesity is Associated with Poor Prognosis in Pancreatic Adenocarcinoma | ||
| 919 | ‡a gemcitabinebasedneoadjuvantchemoradiotherapytherapyinpatientswithborderlineresectablepancreaticcancer ‡A Gemcitabine based neoadjuvant chemoradiotherapy therapy in patients with borderline resectable pancreatic cancer. ‡9 1 | ||
| 919 | ‡a clinicopathologiccharacteristicsassociatedwithcomplicationsandlongtermoutcomesofendoscopicpapillectomyforadenoma ‡A Clinicopathologic characteristics associated with complications and long-term outcomes of endoscopic papillectomy for adenoma ‡9 1 | ||
| 919 | ‡a visceralobesityisassociatedwithpoorprognosisinpancreaticadenocarcinoma ‡A Visceral Obesity is Associated with Poor Prognosis in Pancreatic Adenocarcinoma ‡9 1 | ||
| 919 | ‡a usefulnessof18ffluorodeoxyglucosepositronemissiontomographyindifferentialdiagnosisandstagingofcholangiocarcinomas ‡A Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. ‡9 1 | ||
| 919 | ‡a urgentendoscopicretrogradecholangiopancreatographyisnotsuperiortoearlyercpinacutebiliarypancreatitiswithbiliaryobstructionwithoutcholangitis ‡A Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis ‡9 1 | ||
| 919 | ‡a tuberculousmesentericlymphadenitisinvolvingthegastricwallcasereport ‡A Tuberculous mesenteric lymphadenitis involving the gastric wall: case report ‡9 1 | ||
| 919 | ‡a significanceoftheprognosticnutritionalindexforallstagesofpancreaticcancer ‡A The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer ‡9 1 | ||
| 919 | ‡a relationshipofanatomicvariationofpancreaticductalsystemandpancreaticobiliarydiseases ‡A The relationship of anatomic variation of pancreatic ductal system and pancreaticobiliary diseases. ‡9 1 | ||
| 919 | ‡a efficacyofendoscopicpalliationofobstructivejaundiceinhepatocellularcarcinoma ‡A The efficacy of endoscopic palliation of obstructive jaundice in hepatocellular carcinoma ‡9 1 | ||
| 919 | ‡a efficacyandtreatmentrelatedadverseeventsofgemcitabineplusnabpaclitaxelfortreatmentofmetastaticpancreaticcancerinakoreanpopulationasinglecentercohortstudy ‡A Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort study ‡9 1 | ||
| 919 | ‡a clinicalusefulnessof18fluorodeoxyglucosepositronemissiontomographyinthedifferentialdiagnosisstagingandresponseevaluationafterconcurrentchemoradiotherapyforpancreaticcancer ‡A The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. ‡9 1 | ||
| 919 | ‡a signetringcellcarcinomaoftheextrahepaticbileduct ‡A Signet ring cell carcinoma of the extrahepatic bile duct. ‡9 1 | ||
| 919 | ‡a radiotherapyprolongsbiliarymetalstentpatencyinmalignantpancreatobiliaryobstructions ‡A Radiotherapy prolongs biliary metal stent patency in malignant pancreatobiliary obstructions. ‡9 1 | ||
| 919 | ‡a prospectivestudyforcomparisonofendoscopicultrasoundguidedtissueacquisitionusing25and22gaugecorebiopsyneedlesinsolidpancreaticmasses ‡A Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses ‡9 1 | ||
| 919 | ‡a assessmentoftheriskofcolorectalcancersurvivorsdevelopinga2primarypancreaticcancer ‡A Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. ‡9 1 | ||
| 919 | ‡a bestoptionsforpreoperativebiliarydrainageinpatientswithklatskintumors ‡A Best options for preoperative biliary drainage in patients with Klatskin tumors ‡9 1 | ||
| 919 | ‡a clinicalfeaturesandoutcomesofprimaryhepaticneuroendocrinecarcinomas ‡A Clinical features and outcomes of primary hepatic neuroendocrine carcinomas. ‡9 1 | ||
| 919 | ‡a clinicopathologicfeaturesandoutcomesofpancreaticcystsduringa12yearperiod ‡A Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period ‡9 1 | ||
| 919 | ‡a brca2mutationsasauniversalriskfactorforpancreaticcancerhasalimitedroleinkoreanethnicgroup ‡A BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group. ‡9 1 | ||
| 919 | ‡a hepatoidcarcinomaofthepancreascombinedwithneuroendocrinecarcinoma ‡A Hepatoid carcinoma of the pancreas combined with neuroendocrine carcinoma. ‡9 1 | ||
| 919 | ‡a preoperativeserumca199levelasapredictivefactorforrecurrenceaftercurativeresectioninbiliarytractcancer ‡A Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. ‡9 1 | ||
| 919 | ‡a phase2trialofs1andconcurrentradiotherapyinpatientswithlocallyadvancedpancreaticcancer ‡A Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer. ‡9 1 | ||
| 919 | ‡a endoscopictreatmentofapediatricpatientwithacutepancreatitiscausedbyanomalousunionofpancreaticobiliaryductcombinedwithincompletepancreaticdivisum ‡A Endoscopic treatment of a pediatric patient with acute pancreatitis caused by anomalous union of pancreaticobiliary duct combined with incomplete pancreatic divisum ‡9 1 | ||
| 919 | ‡a bileacidanalysisinbiliarytractcancer ‡A Bile acid analysis in biliary tract cancer. ‡9 1 | ||
| 919 | ‡a phase2trialoferlotinibplusgemcitabinechemotherapyinkoreanpatientswithadvancedpancreaticcancerandprognosticfactorsforchemotherapeuticresponse ‡A Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response ‡9 1 | ||
| 919 | ‡a hepaticarterypseudoaneurysmassociatedwithplasticbiliarystent ‡A Hepatic artery pseudoaneurysm associated with plastic biliary stent ‡9 1 | ||
| 919 | ‡a phase2studyofgemcitabineandcisplatininadvancedbiliarytractcancer ‡A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. ‡9 1 | ||
| 919 | ‡a phase2studyof5fluorouracilandpaclitaxelinpatientswithgemcitabinerefractorypancreaticcancer ‡A Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer. ‡9 1 | ||
| 919 | ‡a comparisonofoutcomesamongsecondarycoveredmetallicuncoveredmetallicandplasticbiliarystentsintreatingoccludedprimarymetallicstentsinmalignantdistalbiliaryobstruction ‡A Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction. ‡9 1 | ||
| 919 | ‡a efficacyofconcurrentchemoradiotherapywith5fluorouracilorgemcitabineinlocallyadvancedbiliarytractcancer ‡A Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer. ‡9 1 | ||
| 919 | ‡a concomitantstatinusehasafavorableeffectongemcitabineerlotinibcombinationchemotherapyforadvancedpancreaticcancer ‡A Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer ‡9 1 | ||
| 919 | ‡a clinicalcharacteristicsoflongtermsurvivorsofinoperablepancreaticcanceran8yearcohortanalysisinkorea ‡A Clinical characteristics of long-term survivors of inoperable pancreatic cancer: an 8-year cohort analysis in Korea. ‡9 1 | ||
| 919 | ‡a paclitaxelaugmentscytotoxiceffectofphotodynamictherapyusingverteporfiningastricandbileductcancercells ‡A Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells. ‡9 1 | ||
| 919 | ‡a canmetforminchangetheprognosisofpancreaticcancerretrospectivestudyforpancreaticcancerpatientswithpreexistingdiabetesmellitustype2 ‡A Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2. ‡9 1 | ||
| 919 | ‡a longtermfollowupofgallbladderpolyps ‡A Long-term follow up of gallbladder polyps. ‡9 1 | ||
| 919 | ‡a hypoechoicfocioneusaresimpleandstrongpredictivefactorsforneoplasticgallbladderpolyps ‡A Hypoechoic foci on EUS are simple and strong predictive factors for neoplastic gallbladder polyps. ‡9 1 | ||
| 919 | ‡a highserumca199levelsareassociatedwithanincreasedriskofcholangiocarcinomainpatientswithintrahepaticductstonesacasecontrolstudy ‡A High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study. ‡9 1 | ||
| 996 | ‡2 ISNI|0000000054088600 | ||
| 996 | ‡2 ISNI|0000000473917186 | ||
| 996 | ‡2 DNB|1158574452 | ||
| 996 | ‡2 ISNI|0000000493219756 | ||
| 996 | ‡2 ISNI|0000000476454981 | ||
| 996 | ‡2 ISNI|0000000499636569 | ||
| 996 | ‡2 ISNI|0000000463238673 | ||
| 996 | ‡2 ISNI|0000000463322912 | ||
| 996 | ‡2 ISNI|0000000464628243 | ||
| 996 | ‡2 LC|n 86857922 | ||
| 996 | ‡2 ISNI|0000000478814856 | ||
| 996 | ‡2 DNB|1190063956 | ||
| 996 | ‡2 ISNI|0000000027618864 | ||
| 996 | ‡2 ISNI|0000000463344249 | ||
| 996 | ‡2 LC|no2018139009 | ||
| 996 | ‡2 ISNI|0000000493420388 | ||
| 996 | ‡2 BIBSYS|90953537 | ||
| 996 | ‡2 ISNI|000000049309413X | ||
| 996 | ‡2 ISNI|0000000463409356 | ||
| 996 | ‡2 J9U|987007605631105171 | ||
| 996 | ‡2 SUDOC|279410549 | ||
| 996 | ‡2 ISNI|0000000473351848 | ||
| 996 | ‡2 ISNI|0000000459479589 | ||
| 996 | ‡2 LC|n 2017051819 | ||
| 996 | ‡2 NII|DA08067151 | ||
| 996 | ‡2 ISNI|0000000492029790 | ||
| 996 | ‡2 ISNI|000000001663878X | ||
| 996 | ‡2 ISNI|0000000476864438 | ||
| 996 | ‡2 ISNI|0000000385583374 | ||
| 996 | ‡2 CAOONL|ncf11480079 | ||
| 996 | ‡2 ISNI|0000000467678756 | ||
| 996 | ‡2 ISNI|0000000503916919 | ||
| 996 | ‡2 ISNI|0000000473535719 | ||
| 996 | ‡2 ISNI|0000000478788352 | ||
| 996 | ‡2 ISNI|0000000463379097 | ||
| 996 | ‡2 BIBSYS|90725399 | ||
| 996 | ‡2 ISNI|000000050534407X | ||
| 996 | ‡2 ISNI|0000000485113804 | ||
| 996 | ‡2 ISNI|0000000494001759 | ||
| 996 | ‡2 ISNI|0000000467854721 | ||
| 996 | ‡2 ISNI|000000047856966X | ||
| 996 | ‡2 ISNI|0000000507238406 | ||
| 996 | ‡2 ISNI|0000000475106248 | ||
| 996 | ‡2 ISNI|0000000460226001 | ||
| 996 | ‡2 CAOONL|ncf11877676 | ||
| 996 | ‡2 ISNI|0000000516764352 | ||
| 996 | ‡2 ISNI|0000000480063318 | ||
| 996 | ‡2 ISNI|0000000492022847 | ||
| 996 | ‡2 ISNI|0000000040095818 | ||
| 996 | ‡2 J9U|987007426062805171 | ||
| 996 | ‡2 ISNI|0000000492304406 | ||
| 996 | ‡2 LC|n 89646970 | ||
| 996 | ‡2 DNB|122454997X | ||
| 996 | ‡2 BNF|15538097 | ||
| 996 | ‡2 ISNI|0000000463238710 | ||
| 996 | ‡2 ISNI|000000050533519X | ||
| 996 | ‡2 ISNI|0000000473833994 | ||
| 996 | ‡2 DNB|1323127682 | ||
| 996 | ‡2 ISNI|0000000503509838 | ||
| 996 | ‡2 LC|n 2005180823 | ||
| 996 | ‡2 RERO|A003106249 | ||
| 996 | ‡2 ISNI|0000000080808990 | ||
| 996 | ‡2 ISNI|0000000114531513 | ||
| 996 | ‡2 DNB|132209659 | ||
| 996 | ‡2 NKC|jo2014834790 | ||
| 996 | ‡2 ISNI|000000047475143X | ||
| 996 | ‡2 ISNI|000000047786240X | ||
| 996 | ‡2 ISNI|0000000504984032 | ||
| 996 | ‡2 LC|n 2020013395 | ||
| 996 | ‡2 ISNI|000000046479783X | ||
| 996 | ‡2 DNB|1035179547 | ||
| 996 | ‡2 ISNI|000000050522940X | ||
| 996 | ‡2 SUDOC|059362332 | ||
| 996 | ‡2 ISNI|0000000046901374 | ||
| 996 | ‡2 SUDOC|108890279 | ||
| 996 | ‡2 LC|nr 99019546 | ||
| 996 | ‡2 ISNI|0000000468088045 | ||
| 996 | ‡2 ISNI|0000000503916839 | ||
| 996 | ‡2 ISNI|0000000000336090 | ||
| 996 | ‡2 DNB|1302771663 | ||
| 996 | ‡2 ISNI|0000000473438644 | ||
| 996 | ‡2 ISNI|0000000471434703 | ||
| 996 | ‡2 DNB|1252303602 | ||
| 996 | ‡2 ISNI|0000000475292685 | ||
| 996 | ‡2 ISNI|0000000464807612 | ||
| 996 | ‡2 LC|n 86071162 | ||
| 996 | ‡2 SUDOC|263985970 | ||
| 996 | ‡2 LC|n 2023055695 | ||
| 996 | ‡2 ISNI|0000000473383604 | ||
| 996 | ‡2 ISNI|0000000513170436 | ||
| 996 | ‡2 NTA|314707107 | ||
| 996 | ‡2 ISNI|0000000459458542 | ||
| 996 | ‡2 J9U|987007336018305171 | ||
| 996 | ‡2 ISNI|0000000473996566 | ||
| 996 | ‡2 ISNI|0000000473377503 | ||
| 996 | ‡2 ISNI|0000000464422982 | ||
| 996 | ‡2 ISNI|0000000509457565 | ||
| 996 | ‡2 CAOONL|ncf11256346 | ||
| 996 | ‡2 NDL|001169657 | ||
| 996 | ‡2 ISNI|0000000476424870 | ||
| 996 | ‡2 ISNI|0000000493091078 | ||
| 996 | ‡2 ISNI|0000000509452019 | ||
| 996 | ‡2 ISNI|0000000483493380 | ||
| 996 | ‡2 ISNI|0000000464479911 | ||
| 996 | ‡2 BNF|12209251 | ||
| 996 | ‡2 ISNI|000000004030099X | ||
| 996 | ‡2 ISNI|0000000464814978 | ||
| 996 | ‡2 LC|n 2023067746 | ||
| 996 | ‡2 BIBSYS|58019 | ||
| 996 | ‡2 ISNI|0000000509370873 | ||
| 996 | ‡2 ISNI|0000000475184465 | ||
| 996 | ‡2 LC|n 2001105108 | ||
| 996 | ‡2 DNB|1139461923 | ||
| 996 | ‡2 ISNI|0000000464601542 | ||
| 996 | ‡2 NII|DA13289006 | ||
| 996 | ‡2 ISNI|000000047790231X | ||
| 996 | ‡2 NUKAT|n 2011154217 | ||
| 996 | ‡2 ISNI|0000000493103104 | ||
| 996 | ‡2 CAOONL|ncf12123514 | ||
| 996 | ‡2 ISNI|0000000463655602 | ||
| 996 | ‡2 CAOONL|ncf11467493 | ||
| 996 | ‡2 ISNI|0000000468507406 | ||
| 996 | ‡2 ISNI|0000000473628472 | ||
| 996 | ‡2 ISNI|0000000492019461 | ||
| 996 | ‡2 ISNI|0000000463408951 | ||
| 996 | ‡2 ISNI|0000000474718461 | ||
| 996 | ‡2 ISNI|0000000493143309 | ||
| 996 | ‡2 ISNI|0000000479348092 | ||
| 996 | ‡2 ISNI|0000000055680964 | ||
| 996 | ‡2 ISNI|0000000479299876 | ||
| 996 | ‡2 NTA|39746813X | ||
| 996 | ‡2 LC|n 87137052 | ||
| 996 | ‡2 SUDOC|06695018X | ||
| 996 | ‡2 DNB|113258843X | ||
| 996 | ‡2 NUKAT|n 2012163199 | ||
| 996 | ‡2 SUDOC|110121074 | ||
| 996 | ‡2 ISNI|0000000464891519 | ||
| 996 | ‡2 ISNI|0000000473920705 | ||
| 996 | ‡2 DNB|1138593133 | ||
| 996 | ‡2 ISNI|0000000473804456 | ||
| 996 | ‡2 ISNI|0000000460155813 | ||
| 996 | ‡2 DNB|173128890 | ||
| 996 | ‡2 LC|n 2015180952 | ||
| 996 | ‡2 DNB|133134105 | ||
| 996 | ‡2 PLWABN|9812396469605606 | ||
| 996 | ‡2 J9U|987007305969405171 | ||
| 996 | ‡2 DNB|1161354115 | ||
| 996 | ‡2 ISNI|0000000475184676 | ||
| 996 | ‡2 DNB|130377694 | ||
| 996 | ‡2 DNB|1177946785 | ||
| 996 | ‡2 ISNI|0000000464377325 | ||
| 996 | ‡2 LC|n 93057201 | ||
| 996 | ‡2 NTA|33327041X | ||
| 996 | ‡2 RERO|A017821046 | ||
| 996 | ‡2 NUKAT|n 2011080753 | ||
| 996 | ‡2 LC|n 85262403 | ||
| 996 | ‡2 ISNI|0000000492262656 | ||
| 996 | ‡2 ISNI|0000000493264506 | ||
| 996 | ‡2 ISNI|0000000478838591 | ||
| 996 | ‡2 ISNI|0000000494055108 | ||
| 996 | ‡2 ISNI|0000000473900616 | ||
| 996 | ‡2 ISNI|0000000082038176 | ||
| 996 | ‡2 ISNI|0000000474203548 | ||
| 996 | ‡2 SUDOC|195114248 | ||
| 996 | ‡2 ISNI|0000000461102668 | ||
| 996 | ‡2 DNB|170706532 | ||
| 996 | ‡2 ISNI|0000000503367403 | ||
| 996 | ‡2 LC|n 97110261 | ||
| 996 | ‡2 RERO|A003106248 | ||
| 996 | ‡2 ISNI|0000000081924643 | ||
| 996 | ‡2 ISNI|0000000473494996 | ||
| 996 | ‡2 ISNI|0000000467855812 | ||
| 996 | ‡2 LC|nr 91034158 | ||
| 996 | ‡2 SUDOC|116524456 | ||
| 996 | ‡2 ISNI|0000000027088672 | ||
| 996 | ‡2 ISNI|0000000460686630 | ||
| 996 | ‡2 ISNI|0000000461117229 | ||
| 996 | ‡2 ISNI|0000000463409110 | ||
| 996 | ‡2 ISNI|0000000035100512 | ||
| 996 | ‡2 NTA|142927325 | ||
| 996 | ‡2 ISNI|0000000464720584 | ||
| 996 | ‡2 LC|nr2002002812 | ||
| 996 | ‡2 NII|DA12763553 | ||
| 996 | ‡2 ISNI|0000000509370232 | ||
| 996 | ‡2 J9U|987007376698705171 | ||
| 996 | ‡2 ISNI|0000000464695673 | ||
| 996 | ‡2 ISNI|0000000464711186 | ||
| 996 | ‡2 BIBSYS|1678650010706 | ||
| 996 | ‡2 ISNI|0000000461040663 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
